Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: 2017 | 2015 | 2014
Number of items: 13.

2017

Dreger, P., Michallet, M., Bosman, P., Sobh, M., Boumendil, A., Nagler, A., Scheid, C., Cornelissen, J., Mueller, L., Niederwieser, D., Vandenberghe, E., Scortechini, I., Schoemans, H., Andersen, N., Finke, J., Russo, D., Ljungman, P., Passweg, J., van Gelder, M., Durakovic, N., Labussiere, H., Berg, T., Wulf, G., Bethge, W., Stilgenbauer, S., Mordini, N., Schaap, M., Fox, C., Kroeger, N., Montoto, S. and Schetelig, J. (2017). Ibrutinib for bridging to allogeneic hematopoietic stem cell transplantation (alloHCT) in chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) is safe and effective: Updated results of a study by the EBMT Chronic Malignancy and Lymphoma Working Parties, the French Cooperative Group for CLL, and the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC). Bone Marrow Transplant., 52. S. S99 - 1. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365

Giannotti, F., Labopin, M., Ruggeri, A., Ehninger, G., Niederwieser, D., Stelljes, M., Stuhler, G., Kroeger, N., Einsele, H., Eder, M., Hallek, M., Glass, B., Finke, J., Ciceri, F., Mohty, M. and Nagler, A. (2017). Outcomes after matched unrelated donor and non-T-cell depleted haploidentical stem cell transplantation in patients >= 60 years with acute myeloid leukemia: A comparative study on behalf of the ALWP of the EBMT. Bone Marrow Transplant., 52. S. S36 - 2. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365

Greinix, H., Beohou, E., van der Werf, S., Niederwieser, D., Blaise, D., Dreger, P., Arnold, R., Meijer, E., Sengeloev, H., Cornelissen, J., Hallek, M., Socie, G., Chevallier, P., Ganser, A., Milpied, N., Maertens, J., Petersen, E., Afanasyev, B., Ehninger, G., Fegueux, N., Jindra, P., Kroeger, N., Montoto, S., Nagler, A. and Duarte, R. (2017). Impact of ATG use on the outcome of patients with hematological malignancies undergoing reduced-intensity conditioning for allogeneic hematopoietic cell transplantation. Bone Marrow Transplant., 52. S. S61 - 1. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365

Jagasia, M., Beohou, E., van der Werf, S., Niederwieser, D., Dreger, P., Meijer, E., Chevallier, P., Sengeloev, H., Blaise, D., Petersen, E., Cornelissen, J. J., Ehninger, G., Gribben, J., Caballero, D., Beguin, Y., Hallek, M., Jindra, P., Fanin, R., Delage, J., Maertens, J., Gedde-Dahl, T., Montoto, S., Kroger, N., Greinix, H. and Duarte, R. (2017). Addition of rituximab in reduced intensity conditioning regimens for B-cell malignancies does not influence transplant outcomes: an EBMT registry analyses. Bone Marrow Transplant., 52. S. S83 - 1. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365

2015

Heidenreich, S., Zabelina, T., van Biezen, A., Finke, J., Platzbecker, U., Niederwieser, D., Einsele, H., Bethge, W., Schwerdtfeger, R., Beelen, D., Tischer, J., Nagler, A., Zachee, P., Scheid, C., de Witte, T., Robin, M. and Kroger, N. (2015). Allogeneic stem cell transplantation for MDS patients more than 70 years of age. A report of MDS subcommittee of CMWP of EBMT. Bone Marrow Transplant., 50. S. S305 - 2. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365

Heidenreich, S., Zabelina, T., van Biezen, A., Finke, J., Platzbecker, U., Niederwieser, D., Einsele, H., Bethge, W., Schwerdtfeger, R., Beelen, D., Tischer, J., Nagler, A., Zachee, P., Scheid, C., de Witte, T., Robin, M. and Kroger, N. (2015). Allogeneic stem cell transplantation for MDS patients more than 70 years of age. A report of MDS subcommittee of CMWP of EBMT. Bone Marrow Transplant., 50. S. S305 - 2. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365

Kroeger, N., Brand, R., Niederwieser, D., Platzbecker, U., Huebel, K., Weber, T., Robin, M., Stelljes, M., Afanasiev, B., Heim, D., Deliliers, G. Lambertenghi, Onida, F., Dreger, P., Pini, M., Guidi, S., Volin, L., Gramatzki, M., Bethge, W., Poire, X., Kobbe, G., van Os, M., Iacobelli, S. and de Witte, T. (2015). RIC vs. MAC followed by allogeneic stem cell transplantation for patients with MDS or secondary AML: A prospective, randomized phase III study of the CMWP of the EBMT (RICMAC-Trial). Bone Marrow Transplant., 50. S. S5 - 1. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365

Kroeger, N., Brand, R., Niederwieser, D., Platzbecker, U., Huebel, K., Weber, T., Robin, M., Stelljes, M., Afanasiev, B., Heim, D., Deliliers, G. Lambertenghi, Onida, F., Dreger, P., Pini, M., Guidi, S., Volin, L., Gramatzki, M., Bethge, W., Poire, X., Kobbe, G., van Os, M., Iacobelli, S. and de Witte, T. (2015). RIC vs. MAC followed by allogeneic stem cell transplantation for patients with MDS or secondary AML: A prospective, randomized phase III study of the CMWP of the EBMT (RICMAC-Trial). Bone Marrow Transplant., 50. S. S5 - 1. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365

Savani, B., Labopin, M., Polge, E., Niederwieser, D., Ganser, A., Ehninger, G., Bornhaeuser, M., Renate, A., Finke, J., Kroeger, N., Craddock, C., Schwerdtfeger, R., Hallek, M., Jindra, P., Mohty, M. and Nagler, A. (2015). Influence of HLA-matching after reduced intensity conditioning regimen and unrelated donor allo-SCT for acute leukemia in patients older than 50 years - a report from the acute leukemia working party of the EBMT. Bone Marrow Transplant., 50. S. S28 - 1. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365

Savani, B., Labopin, M., Polge, E., Niederwieser, D., Ganser, A., Ehninger, G., Bornhaeuser, M., Renate, A., Finke, J., Kroeger, N., Craddock, C., Schwerdtfeger, R., Hallek, M., Jindra, P., Mohty, M. and Nagler, A. (2015). Influence of HLA-matching after reduced intensity conditioning regimen and unrelated donor allo-SCT for acute leukemia in patients older than 50 years - a report from the acute leukemia working party of the EBMT. Bone Marrow Transplant., 50. S. S28 - 1. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365

Scheid, C., Holtick, U., Bornhaeuser, M., Kroeger, N., Ganser, A., Arnold, R., Dreger, P., Stuhler, G., Theobald, M., Peschel, C., Hallek, M., Niederwieser, D., Finke, J., Hertenstein, B. and Beelen, D. (2015). Effects of Busulfan dose and administration route on transplantation outcome in adult patients with AML or MDS - a retrospective analysis of the German transplant registry DRST. Bone Marrow Transplant., 50. S. S224 - 2. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365

Scheid, C., Holtick, U., Bornhaeuser, M., Kroeger, N., Ganser, A., Arnold, R., Dreger, P., Stuhler, G., Theobald, M., Peschel, C., Hallek, M., Niederwieser, D., Finke, J., Hertenstein, B. and Beelen, D. (2015). Effects of Busulfan dose and administration route on transplantation outcome in adult patients with AML or MDS - a retrospective analysis of the German transplant registry DRST. Bone Marrow Transplant., 50. S. S224 - 2. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365

2014

Koenigsmann, M., Casper, J., Kahl, C., Basara, N., Sayer, H. G., Behre, G., Theurich, S., Christopeit, M., Mohren, M., Reichle, A., Metzner, B., Ganser, A., Stadler, M., Uharek, L., Balleisen, L., Hinke, A., Hinke, R. and Niederwieser, D. (2014). Risk-adapted, treosulfan-based therapy with auto- and allo-SCT for relapsed/refractory aggressive NHL: a prospective phase-II trial. Bone Marrow Transplant., 49 (3). S. 410 - 416. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365

This list was generated on Tue Apr 20 05:09:11 2021 CEST.